Treace Medical Concepts (TMCI) Accumulated Depreciation & Amortization (2020 - 2025)
Historic Accumulated Depreciation & Amortization for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $21.8 million.
- Treace Medical Concepts' Accumulated Depreciation & Amortization rose 5495.23% to $21.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.8 million, marking a year-over-year increase of 5495.23%. This contributed to the annual value of $15.3 million for FY2024, which is 7495.43% up from last year.
- Treace Medical Concepts' Accumulated Depreciation & Amortization amounted to $21.8 million in Q3 2025, which was up 5495.23% from $19.6 million recorded in Q2 2025.
- Over the past 5 years, Treace Medical Concepts' Accumulated Depreciation & Amortization peaked at $21.8 million during Q3 2025, and registered a low of $117000.0 during Q1 2021.
- In the last 5 years, Treace Medical Concepts' Accumulated Depreciation & Amortization had a median value of $6.0 million in 2023 and averaged $8.4 million.
- In the last 5 years, Treace Medical Concepts' Accumulated Depreciation & Amortization tumbled by 6151.32% in 2021 and then skyrocketed by 241880.34% in 2022.
- Over the past 5 years, Treace Medical Concepts' Accumulated Depreciation & Amortization (Quarter) stood at $2.7 million in 2021, then soared by 55.64% to $4.3 million in 2022, then skyrocketed by 105.21% to $8.7 million in 2023, then soared by 74.95% to $15.3 million in 2024, then surged by 42.29% to $21.8 million in 2025.
- Its Accumulated Depreciation & Amortization was $21.8 million in Q3 2025, compared to $19.6 million in Q2 2025 and $17.6 million in Q1 2025.